Catalogue Number: 18163-IBL
|Manufacturer:||IBL - (Immuno-Biologicals Laboratories Co Ltd)|
|Physical state:||Lyophilized product from 1 % BSA in PBS containing 0.05% NaN3|
|Type:||Polyclonal Primary Antibody - Unconjugated|
|Shipping Condition:||Blue Ice|
|Unit(s):||100 ug, 2x5 ug|
|Immunogen:||Synthetic peptide of the C terminal part of Human FHIT|
Description: A candidate tumor suppressor gene, FHIT, was indicated at chromosome 3p14.2 spanning the FRA3B common fragile site. Abnormalities in structure and expression of the FHIT gene have been detected in a considerable fraction of lung tumors of small and non-small cell types. There are several reports on the correlations between abnormalities of the FHIT gene and clinicopathological features in lung cancer.
The specific was confirmed against various human cell lines and peripheral blood lymphocyte by WB, and against various human normal tissue by IHC.